BOSTON, United States and ROLLE, Switzerland, April 23, 2024 — SOPHiA GENETICS, a...
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa
Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout...
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
European-based Unilabs has deployed the SOPHiA DDM™ Platform across its network in Switzerland to...
Decoding complexity: Tackling real-world challenges in variant analysis
Welcome to the inaugural episode of our new webinar series - Decoding complexity: Tackling...
Laboratorio Barnafi-Krause is Live on SOPHiA DDM™
The Chile-based Laboratory is using SOPHiA GENETICS’ platform to advance its research capabilities...
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership
The companies will join forces to advance the use of precision medicine on a global scale ...
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada
University of Saskatchewan’s (USask) Advanced Diagnostics Research Laboratory will use SOPHiA DDM™...
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration
New Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer...
ESGO Poster spotlight
Watch our poster spotlight interview, hosting Dr.Gardenia Vargas from Hospital del Mar in Barcelona, Spain discussing the poster presentation at ESGO 2024: “Multicenter Study To Validate And Implement SOPHiA DDM™ HRD Solution For Enhanced Molecular Diagnosis Of Ovarian Cancer.“
Article Spotlight: Machine learning-powered prediction of kidney cancer recurrence
Discover how we collaborated with the UroCCR network to develop a machine learning model that outperformed the predictive performance of most usual kidney cancer risk scores.
SOPHiA GENETICS Announces New Customer in Costa Rica
Universidad de Costa Rica is live on SOPHiA GENETICS’ technology Boston, MA and Rolle,...
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
Strong momentum to continue in 2024 as SOPHiA GENETICS announces record revenue, 35 new customer...